6 Recruiting Low Grade Glioma Phase 2 Clinical Trials
Active phase 2 studies for low grade glioma enrolling across the USA. Verify eligibility and contact site coordinators.
All Low Grade Glioma studiesPhase 2 Studies for Low Grade Glioma
🔵 Active, Not Recruiting Phase2
Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase2
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Vaccine Trial for Low Grade Gliomas
📍 Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania
View Study & Checklist ➔